Milanova Tsveta

Insider profile

Milanova Tsveta's trades of Agios Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-04-06 2026-04-02 PlS Planned sale
22,089 -36.5%
61.99
US$4,143,018
22,089 -36.5% 61.99 US$4,143,018
2026-04-02 2026-04-02 PrS Proposed sale
36,414
310.44
US$1,579,689
36,414 310.44 US$1,579,689
2026-03-03 2026-03-02 PlS Planned sale
76,358 +14.8%
398.51
US$2,601,408
76,358 +14.8% 398.51 US$2,601,408
2026-03-03 2026-03-02 PlS Planned sale
1,681 -4.2%
28.96
US$48,682
1,681 -4.2% 28.96 US$48,682
2026-03-02 2026-03-02 PrS Proposed sale
2,868
30.23
US$86,700
2,868 30.23 US$86,700
2026-01-07 2026-01-05 PlS Planned sale
2,872 -7.6%
27.02
US$77,601
2,872 -7.6% 27.02 US$77,601
2026-01-05 2026-01-05 PrS Proposed sale
2,872
27.22
US$78,176
2,872 27.22 US$78,176
2026-01-02 2025-12-30 PlS Planned sale
2,932 -9.1%
27.09
US$79,428
2,932 -9.1% 27.09 US$79,428
2025-12-30 2025-12-30 PrS Proposed sale
2,932
27.16
US$79,633
2,932 27.16 US$79,633
2025-06-26 2025-06-24 PlS Planned sale
2,770 -9.6%
33.54
US$92,906
2,770 -9.6% 33.54 US$92,906
2025-06-24 2025-06-24 PrS Proposed sale
1,761
34.41
US$60,596
1,761 34.41 US$60,596
2025-03-04 2025-03-03 PlS Planned sale
1,681 -6.8%
35.54
US$59,743
1,681 -6.8% 35.54 US$59,743
2025-03-03 2025-03-03 PrS Proposed sale
1,681
35.54
US$59,743
1,681 35.54 US$59,743
2025-01-07 2025-01-06 PlS Planned sale
2,804 -12.9%
32.18
US$90,233
2,804 -12.9% 32.18 US$90,233
2025-01-03 2025-01-03 PrS Proposed sale
2,804
31.84
US$89,279
2,804 31.84 US$89,279
2024-01-24 2024-01-24 PlS Planned sale
1,618 -10.9%
21.64
US$35,014
1,618 -10.9% 21.64 US$35,014
2024-01-05 2024-01-05 PlS Planned sale
2,902 -23.6%
22.32
US$64,773
2,902 -23.6% 22.32 US$64,773